Clinical Trials Browser

Phase 1 × metarrestin × 30 days × Clear all

NCT04222413 2026-03-13

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Phase 1 Recruiting

GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma